Copyright
©The Author(s) 2025.
World J Psychiatry. Jan 19, 2025; 15(1): 98737
Published online Jan 19, 2025. doi: 10.5498/wjp.v15.i1.98737
Published online Jan 19, 2025. doi: 10.5498/wjp.v15.i1.98737
Group | CD4+ (%) | CD8+ (%) | CD4+/CD8+ | |||
Before intervention | After intervention | Before intervention | After intervention | Before intervention | After intervention | |
Conventional group (n= 55) | 31.43 ± 1.62 | 36.10 ± 1.87a | 42.06 ± 1.87 | 40.35 ± 1.72a | 0.75 ± 0.05 | 0.90 ± 0.06a |
Joint intervention group (n= 55) | 31.16 ± 1.54 | 41.04 ± 2.30a | 42.52 ± 1.60 | 39.66 ± 1.52a | 0.73 ± 0.04 | 1.03 ± 0.08a |
t value | 0.919 | -12.331 | -1.403 | 2.259 | 1.772 | -11.054 |
P value | 0.360 | < 0.001 | 0.163 | 0.026 | 0.079 | < 0.001 |
- Citation: Liu J, Guo YP, Lu YM, Wang BL. Clinical value of combining epirubicin with mindfulness intervention in patients with urinary system tumors and depression. World J Psychiatry 2025; 15(1): 98737
- URL: https://www.wjgnet.com/2220-3206/full/v15/i1/98737.htm
- DOI: https://dx.doi.org/10.5498/wjp.v15.i1.98737